HDAC1 and atherosclerosis: In summary, we provide preclinical evidence that HDAC1/2 contribute to EC activation promoting atherosclerosis, and we reveal a novel epigenetic mechanism by which HDAC1/2 inhibition attenuates this inflammatory response.